{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:59:31Z","timestamp":1790949571620,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.intimp.2023.111409","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T17:57:43Z","timestamp":1703008663000},"page":"111409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The effects of IGF-1 and IGFBP-2 treatments on the atherosclerosis in the aorta and the coronary arteries of the high cholesterol diet-fed rabbits"],"prefix":"10.1016","volume":"127","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7994-5050","authenticated-orcid":false,"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"De-Gang","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0291-8723","authenticated-orcid":false,"given":"Heng-Chen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.intimp.2023.111409_b0005","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: Recent developments","volume":"185","author":"Bjorkegren","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.intimp.2023.111409_b0010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41392-022-00955-7","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2023.111409_b0015","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s41569-021-00629-x","article-title":"Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis","volume":"19","author":"Chen","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111409_b0020","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.intimp.2023.111409_b0025","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?","volume":"19","author":"Engelen","year":"2022","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.intimp.2023.111409_b0030","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/cvr\/cvy109","article-title":"Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity","volume":"114","author":"Cole","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"19","key":"10.1016\/j.intimp.2023.111409_b0035","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/eurheartj\/ehac094","article-title":"Targeting the CCL2-CCR2 axis for atheroprotection","volume":"43","author":"Georgakis","year":"2022","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.intimp.2023.111409_b0040","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.118.313816","article-title":"Atherosclerosis","volume":"123","author":"Kobiyama","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.intimp.2023.111409_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121244","article-title":"Sustained IGF-1 delivery ameliorates effects of chronic denervation and improves functional recovery after peripheral nerve injury and repair","volume":"280","author":"Hanwright","year":"2022","journal-title":"Biomaterials"},{"issue":"23","key":"10.1016\/j.intimp.2023.111409_b0050","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.116.021805","article-title":"Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice","volume":"133","author":"Higashi","year":"2016","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.intimp.2023.111409_b0055","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab040","article-title":"Hepatic Igf1-Deficiency Protects Against Atherosclerosis in Female Mice","volume":"162","author":"Sivasubramaniyam","year":"2021","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.intimp.2023.111409_b0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/ATVBAHA.121.316090","article-title":"Macrophage-Specific IGF-1 Overexpression Reduces CXCL12 Chemokine Levels and Suppresses Atherosclerotic Burden in Apoe-Deficient Mice","volume":"42","author":"Snarski","year":"2022","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2023.111409_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.908023","article-title":"Insulin-Like Growth Factor 1 Attenuates the Pro-Inflammatory Phenotype of Neutrophils in Myocardial Infarction","volume":"13","author":"Nederlof","year":"2022","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.intimp.2023.111409_b0070","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1161\/ATVBAHA.107.156257","article-title":"IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice","volume":"27","author":"Sukhanov","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.intimp.2023.111409_b0075","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165713","article-title":"Insulin-like growth factor 1 reduces coronary atherosclerosis in pigs with familial hypercholesterolemia","volume":"8","author":"Sukhanov","year":"2023","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.intimp.2023.111409_b0080","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13287-019-1544-y","article-title":"IGF-1 enhances BMSC viability, migration, and anti-apoptosis in myocardial infarction via secreted frizzled-related protein 2 pathway","volume":"11","author":"Lin","year":"2020","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.111409_b0085","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s13287-018-1028-5","article-title":"Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy","volume":"9","author":"Yang","year":"2018","journal-title":"Stem Cell Res. Ther."},{"issue":"9\u201310","key":"10.1016\/j.intimp.2023.111409_b0090","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.lfs.2010.12.021","article-title":"The role of insulin growth factor on atherosclerosis and endothelial function: the effect on hyperlipidemia and aging","volume":"88","author":"Hirai","year":"2011","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2023.111409_b0095","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3389\/fendo.2018.00388","article-title":"Current IGFBP-Related Biomarker Research in Cardiovascular Disease-We Need More Structural and Functional Information in Clinical Studies","volume":"9","author":"Hoeflich","year":"2018","journal-title":"Front. Endocrinol. (lausanne)"},{"issue":"14","key":"10.1016\/j.intimp.2023.111409_b0100","doi-asserted-by":"crossref","first-page":"e020215","DOI":"10.1161\/JAHA.120.020215","article-title":"Cardiovascular Biomarkers of Obesity and Overlap With Cardiometabolic Dysfunction","volume":"10","author":"Lau","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.intimp.2023.111409_b0105","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.atherosclerosis.2014.09.022","article-title":"Circulating IGFBP-2 levels are incrementally linked to correlates of the metabolic syndrome and independently associated with VLDL triglycerides","volume":"237","author":"Carter","year":"2014","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.intimp.2023.111409_b0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031133","article-title":"Potential Role of Insulin Growth-Factor-Binding Protein 2 as Therapeutic Target for Obesity-Related Insulin Resistance","volume":"22","author":"Boughanem","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.intimp.2023.111409_b0115","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2018-01241","article-title":"Cardiometabolic Biomarkers and Their Temporal Patterns Predict Poor Outcome in Chronic Heart Failure (Bio-SHiFT Study)","volume":"103","author":"Brankovic","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.intimp.2023.111409_b0120","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41390-020-01113-x","article-title":"Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survival","volume":"88","author":"Griffiths","year":"2020","journal-title":"Pediatr. Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.111409_b0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1136\/hrt.2006.090092","article-title":"Insulin-like growth factor-binding proteins 2 and 3 are independent predictors of a poor prognosis in patients with dilated cardiomyopathy","volume":"93","author":"Hassfeld","year":"2007","journal-title":"Heart"},{"issue":"20","key":"10.1016\/j.intimp.2023.111409_b0130","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1128\/MCB.01011-12","article-title":"Insulin-like growth factor (IGF) binding protein 2 functions coordinately with receptor protein tyrosine phosphatase beta and the IGF-I receptor to regulate IGF-I-stimulated signaling","volume":"32","author":"Shen","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.intimp.2023.111409_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2023.05.030","article-title":"Circulating IGF-1 and IGFBP-2 may be biomarkers for risk stratification in patients with acute coronary syndrome: A prospective cohort study","author":"Wang","year":"2023","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"10.1016\/j.intimp.2023.111409_b0140","doi-asserted-by":"crossref","first-page":"1126093","DOI":"10.3389\/fcvm.2023.1126093","article-title":"The impact of circulating IGF-1 and IGFBP-2 on cardiovascular prognosis in patients with acute coronary syndrome","volume":"10","author":"Wang","year":"2023","journal-title":"Front. Cardiovasc. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.111409_b0145","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1752-8062.2008.00008.x","article-title":"Simultaneous administration of insulin-like growth factor-1 and darbepoetin alfa protects the rat myocardium against myocardial infarction and enhances angiogenesis","volume":"1","author":"Boucher","year":"2008","journal-title":"Clin. Transl. Sci."},{"issue":"2","key":"10.1016\/j.intimp.2023.111409_b0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"issue":"1","key":"10.1016\/j.intimp.2023.111409_b0155","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/1570161119666210820115150","article-title":"Negatively-charged Liposome Nanoparticles Can Prevent Dyslipidemia and Atherosclerosis Progression in the Rabbit Model","volume":"20","author":"Momtazi-Borojeni","year":"2022","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"5","key":"10.1016\/j.intimp.2023.111409_b0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.21315\/mjms2017.24.5.11","article-title":"Sample Size Calculation in Animal Studies Using Resource Equation Approach","volume":"24","author":"Arifin","year":"2017","journal-title":"Malays J. Med. Sci."},{"issue":"4","key":"10.1016\/j.intimp.2023.111409_b0165","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.1999.00351.x","article-title":"Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress","volume":"55","author":"Galle","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2023.111409_b0170","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2017.02.019","article-title":"Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis","volume":"259","author":"Waldmann","year":"2017","journal-title":"Atherosclerosis"},{"issue":"82","key":"10.1016\/j.intimp.2023.111409_b0175","doi-asserted-by":"crossref","first-page":"20121053","DOI":"10.1098\/rsif.2012.1053","article-title":"In vitro and in vivo investigations on the effects of low-density lipoprotein concentration polarization and haemodynamics on atherosclerotic localization in rabbit and zebrafish","volume":"10","author":"Xie","year":"2013","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.intimp.2023.111409_b0180","article-title":"Overview of OxLDL and Its Impact on Cardiovascular Health: Focus on Atherosclerosis","volume":"11","author":"Poznyak","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2023.111409_b0185","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0022-2275(20)39755-8","article-title":"Role of liver in the synthesis of cholesterol and the clearance of low density lipoproteins in the cynomolgus monkey","volume":"36","author":"Turley","year":"1995","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.intimp.2023.111409_b0190","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/152786","article-title":"LOX-1, OxLDL, and atherosclerosis","volume":"2013","author":"Pirillo","year":"2013","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.intimp.2023.111409_b0195","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ajpath.2010.10.007","article-title":"IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype","volume":"178","author":"von der Thusen","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2023.111409_b0200","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1146\/annurev.med.45.1.361","article-title":"Endothelial-leukocyte adhesion molecules in human disease","volume":"45","author":"Bevilacqua","year":"1994","journal-title":"Annu. Rev. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.111409_b0205","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4049\/jimmunol.147.2.660","article-title":"Differential synthesis of 1-acyl-2-acetyl-sn-glycero-3-phosphocholine and platelet-activating factor by human inflammatory cells","volume":"147","author":"Triggiani","year":"1991","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2023.111409_b0210","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/biof.1883","article-title":"Platelet Activating Factor (PAF): A Mediator of Inflammation","volume":"48","author":"Upton","year":"2022","journal-title":"Biofactors"},{"issue":"4","key":"10.1016\/j.intimp.2023.111409_b0215","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.phrs.2009.01.004","article-title":"Effects of atorvastatin therapy on protein oxidation and oxidative DNA damage in hypercholesterolemic rabbits","volume":"59","author":"Aydin","year":"2009","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.111409_b0220","first-page":"120","article-title":"8-hydroxy-2' -deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis","volume":"27","author":"Valavanidis","year":"2009","journal-title":"J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev."},{"issue":"12","key":"10.1016\/j.intimp.2023.111409_b0225","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3109\/10715760903214470","article-title":"Differences in oxidative stress markers based on the aetiology of heart failure: comparison of oxidative stress in patients with and without coronary artery disease","volume":"43","author":"Nagayoshi","year":"2009","journal-title":"Free Radic. Res."},{"issue":"4","key":"10.1016\/j.intimp.2023.111409_b0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/MCA.0b013e328344b615","article-title":"Association of serum 8-hydroxy-2'-deoxyguanosine levels with the presence and severity of coronary artery disease","volume":"22","author":"Xiang","year":"2011","journal-title":"Coron. Artery Dis."},{"issue":"12","key":"10.1016\/j.intimp.2023.111409_b0235","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1080\/03007995.2022.2096351","article-title":"Rapid improvement in severe long COVID following perispinal etanercept","volume":"38","author":"Tobinick","year":"2022","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.intimp.2023.111409_b0240","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.937201","article-title":"The relationship between dyslipidemia and inflammation among adults in east coast China: A cross-sectional study","volume":"13","author":"Hong","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.111409_b0245","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1186\/ar3874","article-title":"Anti-tumor necrosis factor therapy improves insulin resistance, beta cell function and insulin signaling in active rheumatoid arthritis patients with high insulin resistance","volume":"14","author":"Stagakis","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"20","key":"10.1016\/j.intimp.2023.111409_b0250","doi-asserted-by":"crossref","first-page":"8939","DOI":"10.7150\/thno.45178","article-title":"METTL14 aggravates endothelial inflammation and atherosclerosis by increasing FOXO1 N6-methyladeosine modifications","volume":"10","author":"Jian","year":"2020","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.intimp.2023.111409_b0255","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00296-022-05113-4","article-title":"Assessment of TNF-alpha expression in unstable atherosclerotic plaques, serum IL-6 and TNF-alpha levels in patients with acute coronary syndrome and rheumatoid arthritis","volume":"42","author":"Popova","year":"2022","journal-title":"Rheumatol. Int."},{"issue":"4","key":"10.1016\/j.intimp.2023.111409_b0260","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jpsychores.2014.01.007","article-title":"Interleukin-6 gene polymorphism, chronic stress and atherosclerosis: interleukin-6-174G>C polymorphism, chronic stress and risk of early atherosclerosis in the Cardiovascular Risk in Young Finns Study","volume":"76","author":"Chumaeva","year":"2014","journal-title":"J. Psychosom. Res."},{"issue":"2","key":"10.1016\/j.intimp.2023.111409_b0265","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/ATVBAHA.111.229435","article-title":"Transsignaling of interleukin-6 crucially contributes to atherosclerosis in mice","volume":"32","author":"Schuett","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.intimp.2023.111409_b0270","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jnutbio.2019.04.012","article-title":"Ascorbic acid deficiency increases hepatic expression of acute phase proteins through the intestine-derived IL-6 and hepatic STAT3 pathway in ODS rats","volume":"70","author":"Kawade","year":"2019","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.intimp.2023.111409_b0275","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3389\/fimmu.2019.01407","article-title":"Coagulation and Skin Autoimmunity","volume":"10","author":"Cugno","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2023.111409_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112094","article-title":"IL-6 promotes cell adhesion in human endothelial cells via microRNA-126-3p suppression","volume":"393","author":"Ohta","year":"2020","journal-title":"Exp. Cell Res."},{"issue":"4","key":"10.1016\/j.intimp.2023.111409_b0285","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/09553009514550531","article-title":"Rapid communication: effect of irradiation on lymphocyte proliferation and differentiation: potential of IL-6 in augmenting antibody responses in cultures of murine spleen cells","volume":"67","author":"Goud","year":"1995","journal-title":"Int. J. Radiat Biol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923017368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923017368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T18:13:08Z","timestamp":1761588788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923017368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":57,"alternative-id":["S1567576923017368"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111409","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of IGF-1 and IGFBP-2 treatments on the atherosclerosis in the aorta and the coronary arteries of the high cholesterol diet-fed rabbits","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.111409","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111409"}}